TrialVaccine2011

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania.

Muhammad Bakari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.